Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population.
about
Epidermal growth factor receptor in non-small cell lung cancerThe long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinomaJAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancerMechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
P2860
Q28088636-EF0DD77A-41B9-4EFA-9C79-541394C4DEB8Q35568803-3D354880-4682-466F-9E1B-9975FA7204C5Q35781614-958003F1-B313-4627-81BD-7EB5BAD2695BQ35987345-44E42D69-FD18-46A8-9ADD-D4269F83D0FEQ36188947-8C0FA188-488E-4688-99C5-FA7288376193Q37362819-B1D97192-BC5C-4CCE-B628-B23D8C8DF4E9Q39118597-3927D2DE-9A97-4A7A-A63E-E160A512952AQ52568478-72F248CA-70A0-48A8-8A7D-BA1BCBD5BFD0
P2860
Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Revisiting clinical trials usi ...... cer Center phase I population.
@en
Revisiting clinical trials usi ...... cer Center phase I population.
@nl
type
label
Revisiting clinical trials usi ...... cer Center phase I population.
@en
Revisiting clinical trials usi ...... cer Center phase I population.
@nl
prefLabel
Revisiting clinical trials usi ...... cer Center phase I population.
@en
Revisiting clinical trials usi ...... cer Center phase I population.
@nl
P2093
P2860
P50
P356
P1433
P1476
Revisiting clinical trials usi ...... cer Center phase I population.
@en
P2093
Bettzy Stephen
David Hong
Gerald Falchook
Jansina Y Fok
Jennifer Wheler
Sarina Piha-Paul
P2860
P304
P356
10.18632/ONCOTARGET.1028
P407
P577
2013-05-01T00:00:00Z